ABCL icon

AbCellera Biologics

116 hedge funds and large institutions have $1.98B invested in AbCellera Biologics in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 26 closing their positions.

Holders
116
Holders Change
+2
Holders Change %
+1.75%
% of All Funds
2.04%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.14%
New
28
Increased
48
Reduced
25
Closed
26
Calls
$65.4M
Puts
$30.4M
Net Calls
+$35M
Net Calls Change
+$25.4M
Name Holding Trade Value Shares
Change
Shares
Change %
Capstone Investment Advisors
126
Capstone Investment Advisors
New York
-$1.43M -65,005 Closed
HP
127
Harbourvest Partners
Massachusetts
-$1.3M -59,200 Closed
BC
128
Brookfield Corp
Ontario, Canada
-$1.1M -50,000 Closed
ECM
129
ExodusPoint Capital Management
New York
-$659K -29,972 Closed
RC
130
RBF Capital
California
-$527K -23,948 Closed
BCM
131
Bayesian Capital Management
New York
-$504K -22,900 Closed
Group One Trading
132
Group One Trading
Illinois
-$423K -19,222 Closed
Cerity Partners
133
Cerity Partners
New York
-$374K -17,000 Closed
Verition Fund Management
134
Verition Fund Management
Connecticut
-$334K -15,180 Closed
TC
135
Telemus Capital
Michigan
-$295K -13,400 Closed
HT
136
HAP Trading
New York
-$252K -11,474 Closed
TI
137
Trexquant Investment
Connecticut
-$244K -11,102 Closed
FC
138
FORA Capital
Florida
-$133K -6,029 Closed
SPIA
139
Steward Partners Investment Advisory
New York
-$22K -1,000 Closed
CAPTRUST Financial Advisors
140
CAPTRUST Financial Advisors
North Carolina
-$16K -750 Closed
US Bancorp
141
US Bancorp
Minnesota
-$11K -500 Closed
DFCM
142
Dark Forest Capital Management
Puerto Rico
-$3K -157 Closed